A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Chlorambucil (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 22 Jun 2015 Biomarkers information updated
- 05 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Apr 2013 Planned initiation date changed from 1 Mar 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.